首页> 外文期刊>World Journal of Gastroenterology >Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients.
【24h】

Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients.

机译:胰腺癌患者胰腺,胃和十二指肠中的幽门螺杆菌核糖体DNA。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: To determine whether gastric and enteric Helicobacter species are associated with pancreatic cancer. METHODS: Patients with exocrine pancreatic cancer (n = 40), neuroendocrine cancer (n = 14), multiple endocrine neoplasia type 1 (n = 8), and chronic pancreatitis (n = 5) were studied. Other benign pancreatic diseases (n = 10) and specimens of normal pancreas (n = 7) were included as controls. Pancreatic tissue specimens were analyzed by Helicobacter-specific PCR-assay and products were characterized by denaturing gradient electrophoresis and DNA-sequencing. From a subset of the pancreatic cancer patients, gastric and/or duodenal tissue as well as gallbladder and ductus choledochus tissue were analyzed. Gallbladder and choledochus samples were included as controls. Stomach and duodenum samples were investigated to analyze whether a gastric helicobacter might disseminate to the pancreas in pancreatic cancer patients. Pancreatic specimens were analyzed by Bacteroides-specific PCR for detecting the translocation of indigenous gut microbes to the diseased pancreas. RESULTS: Helicobacter DNA was detected in pancreas (tumor and/or surrounding tissue) of 75% of patients with exocrine cancer, 57% of patients with neuroendocrine cancer, 38% of patients with multiple endocrine neoplasia, and 60% of patients with chronic pancreatitis. All samples from other benign pancreatic diseases and normal pancreas were negative. Thirty-three percent of the patients were helicobacter-positive in gastroduodenal specimens. Surprisingly, H. bilis was identified in 60% of the positive gastroduodenal samples. All gallbladder and ductus choledochus specimens were negative for helicobacter. Bacteroides PCR-assay was negative for all pancreatic samples. CONCLUSION: Helicobacter DNA commonly detected in pancreatic cancer suggests a possible role of the emerging pathogens in the development of chronic pancreatitis and pancreatic cancer.
机译:目的:确定胃和肠杆菌是否与胰腺癌有关。方法:研究了外分泌型胰腺癌(n = 40),神经内分泌癌(n = 14),1型多发性内分泌肿瘤(n = 8)和慢性胰腺炎(n = 5)的患者。其他良性胰腺疾病(n = 10)和正常胰腺标本(n = 7)也作为对照。胰腺组织标本通过幽门螺杆菌特异性PCR分析进行分析,产物通过变性梯度电泳和DNA测序进行表征。从一部分胰腺癌患者中,分析了胃和/或十二指肠组织以及胆囊和导管胆总管组织。胆囊和胆总管样品作为对照。对胃和十二指肠样品进行了调查,以分析胃幽门螺杆菌是否可能扩散到胰腺癌患者的胰腺中。通过细菌特异性PCR分析胰腺标本,以检测本地肠道微生物向患病胰腺的移位。结果:在75%的外分泌癌患者,57%的神经内分泌癌患者,38%的多发性内分泌肿瘤和60%的慢性胰腺炎患者的胰腺(肿瘤和/或周围组织)中检测到了幽门螺杆菌DNA 。来自其他良性胰腺疾病和正常胰腺的所有样品均为阴性。胃十二指肠标本中有33%的患者是幽门螺杆菌阳性。令人惊讶的是,在60%的胃十二指肠阳性样本中发现了H. bilis。所有胆囊和胆总管标本均为幽门螺杆菌阴性。所有胰腺样品的细菌PCR检测均为阴性。结论:通常在胰腺癌中检测到的幽门螺杆菌DNA提示新兴病原体可能在慢性胰腺炎和胰腺癌的发展中可能发挥作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号